Moreover, lncRNA CCDC26, whose expression levels time-dependently reduced by the imatinib exposure, sensitized the secondary resistant GIST cells to imatinib by inhibiting c-KIT (Cao K. et al., 2018). Here, KIT is linked to gastrointestinal stromal tumor.